✦ LIBER ✦

Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: A first step toward implementing a multidisciplinary, evidence-based guideline

✍ Scribed by Hermens, R.P.M.G.; Ouwens, M.M.T.J.; Vonk-Okhuijsen, S.Y.; van der Wel, Y.; Tjan-Heijnen, V.C.G.; van den Broek, L.D.; Ho, V.K.Y.; Janssen-Heijnen, M.L.G.; Groen, H.J.M.; Grol, R.P.T.M.; Wollersheim, H.C.H.

Book ID: 119319455
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 256 KB
Volume: 54
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2006.07.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of a membrane array-based mu

Development of a membrane array-based multimarker assay for detection of circulating cancer cells in patients with non-small cell lung cancer

✍ Chau-Chyun Sheu; Ya-Ping Yu; Jong-Rung Tsai; Mei-Yin Chang; Shiu-Ru Lin; Jhi-Jhu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 373 KB 👁 2 views

## Abstract Combination of multiple mRNA markers has been largely investigated for detection of circulating cancer cells. However, current PCR‐based methods are relatively expensive and time consuming. The aim of this study was to develop a membrane array‐based multimarker assay for detection of ci

PCN142 EVALUATION OF THE QUALITY OF LIFE

PCN142 EVALUATION OF THE QUALITY OF LIFE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WHO FAILED TO FIRST LINE CHEMOTHERAPY IN TREATMENT WITH ERLOTINIB VS TAXANES

✍ J Vargas; JD Gomez Rangel; L Martínez-Barrera; D Mendoza; Á Paladio 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Influence of age, comorbidity and perfor

Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study

✍ de Rijke, J.M.; Schouten, L.J.; Velde, G.P.M.ten; Wanders, S.L.; Bollen, E.C.M.; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Single-agent versus combination chemothe

Single-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: A literature-based meta-analysis of randomized studies

✍ Mörth, Charlott; Valachis, Antonis 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 804 KB

The safety and efficacy of gefitinib ver

The safety and efficacy of gefitinib versus platinum-based doublets chemotherapy as the first-line treatment for advanced non-small-cell lung cancer patients in East Asia: A meta-analysis

✍ Chang, Chia-Hsuin; Chen, Kuan-Yu; Young-Xu, Yinong; Kurth, Tobias; Orav, E. John 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 362 KB

Cost-Effectiveness of EML4-ALK Fusion Te

Cost-Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients with Advanced ALK Positive Non-Small Cell Lung Cancer in a Publicly Funded System (Ontario, Canada)

✍ Djalalov, S.; Beca, J.; Hoch, J.S.; Krahn, M.D.; Tsao, M.S.; Cutz, J.C.; Leighl, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB